Tag:
ustekinumab
Latest Headlines
Latest Headlines
Amgen defends Enbrel after J&J wins trial
A new Johnson & Johnson drug trial has put Amgen on the defensive. According to the
Experimental psoriasis drug beats Enbrel in study
In an unusual head-to-head study, researchers for Johnson & Johnson's Centocor announced that their experimental therapy for psoriasis outperformed the leading biologic therapy in eliminating
FDA committee backs Centocor psoriasis drug
J&J's Centocor won a key vote by an FDA expert committee backing the approval of ustekinumab for severe to moderate psoriasis. But the experts also want to make sure that the developer continues
J&J psoriasis drug may carry cancer risk
Outside experts are preparing to review ustekinumab, Centocor's injectable treatment of severe psoriasis. Two Phase III studies demonstrated
